BE SEMICONDUCTOR And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – BE SEMICONDUCTOR (BESI.AS), VÅR ENERGI (VAR.OL), VOLUE (VOLUE.OL) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. BE SEMICONDUCTOR (BESI.AS)

49.4% sales growth and 40.81% return on equity

BE Semiconductor Industries N.V. engages in the development, manufacture, marketing, sale, and service of semiconductor assembly equipment for the semiconductor and electronics industries in China, the United States, Malaysia, Ireland, Korea, Taiwan, Thailand, Other Asia Pacific and Europe, and internationally. It operates through three segments: Die Attach, Packaging, and Plating. The company's principal products include die attach equipment, such as single chip, multi-chip, multi module, flip chip, thermal compression bonding, fan out wafer level packaging, hybrid and embedded bridge die bonding, and die sorting systems; and packaging equipment, including conventional, ultra-thin, and wafer level molding, as well as trim and form, and singulation systems. It also provides plating equipment, such as tin, copper, and precious metal and solar plating systems, as well as related process chemicals; and tooling, conversion kits, spare parts, and other services. The company's principal brand names include Datacon, Esec, Fico, and Meco. It offers its products primarily to multinational chip manufacturers, assembly subcontractors, and electronics and industrial companies. BE Semiconductor Industries N.V. was incorporated in 1995 and is headquartered in Duiven, the Netherlands.

Earnings Per Share

As for profitability, BE SEMICONDUCTOR has a trailing twelve months EPS of €2.11.

PE Ratio

BE SEMICONDUCTOR has a trailing twelve months price to earnings ratio of 56.21. Meaning, the purchaser of the share is investing €56.21 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 40.81%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 22.7% and positive 71.1% for the next.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Apr 29, 2024, the estimated forward annual dividend rate is 2.15 and the estimated forward annual dividend yield is 2.06%.

More news about BE SEMICONDUCTOR.

2. VÅR ENERGI (VAR.OL)

34.3% sales growth and 50.7% return on equity

Vår Energi AS operates as an independent upstream oil and gas company on the Norwegian continental shelf in Norway. It produces crude oil, liquified natural gas, and natural gas liquids. The company was formerly known as Eni Norge AS and changed its name to Vår Energi AS in December 2018. The company was incorporated in 1965 and is headquartered in Sandnes, Norway. Vår Energi AS operates as a subsidiary of Eni International B.V.

Earnings Per Share

As for profitability, VÅR ENERGI has a trailing twelve months EPS of kr2.72.

PE Ratio

VÅR ENERGI has a trailing twelve months price to earnings ratio of 13.01. Meaning, the purchaser of the share is investing kr13.01 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 50.7%.

Volume

Today’s last reported volume for VÅR ENERGI is 2494850 which is 58.07% below its average volume of 5951320.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Jul 29, 2024, the estimated forward annual dividend rate is 4.74 and the estimated forward annual dividend yield is 13.42%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 20.7% and 138.9%, respectively.

Sales Growth

VÅR ENERGI’s sales growth is 34.6% for the current quarter and 34.3% for the next.

More news about VÅR ENERGI.

3. VOLUE (VOLUE.OL)

18.4% sales growth and 3.92% return on equity

Volue ASA, together with its subsidiaries, engages in the provision of software and technology solutions for the energy, power grid, and infrastructure markets worldwide. It operates through three segments: Energy, Power Grid, and Infrastructure. The Energy segment offers software solutions and consulting services related to forecasting and optimization of the different energy markets that enables end-to-end optimization of the green energy value-chain. The Power Grid segment provides software solutions and consulting services that enables power distributors to support electrification of society by unlocking flexibility and digital management of the power grid. The Infrastructure segment offers software solutions and consulting services that delivers flexible solutions for digital water management. This segment is also involved in the automation of processes and machines for the construction industry. The company was incorporated in 2019 and is headquartered in Oslo, Norway. Volue ASA operates as a subsidiary of Arendals Fossekompani ASA.

Earnings Per Share

As for profitability, VOLUE has a trailing twelve months EPS of kr0.24.

PE Ratio

VOLUE has a trailing twelve months price to earnings ratio of 170. Meaning, the purchaser of the share is investing kr170 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.92%.

Volume

Today’s last reported volume for VOLUE is 185007 which is 0.79% above its average volume of 183555.

Moving Average

VOLUE’s value is way above its 50-day moving average of kr29.59 and way higher than its 200-day moving average of kr23.84.

Sales Growth

VOLUE’s sales growth is 25.4% for the current quarter and 18.4% for the next.

More news about VOLUE.

4. HOLLAND COLOURS (HOLCO.AS)

13.8% sales growth and 8.62% return on equity

Holland Colours N.V., together with its subsidiaries, manufactures, distributes, and sells color concentrates in Europe, North America, Asia, and internationally. The company offers colorants for the building and construction industry, including profiles, pipes, tubing and fittings, siding and cladding, decking, fencing, window blinds, and insulation, as well as solutions for a range of polymers. It offers colorants for packaging applications comprising water, carbonated soft drinks, fruit juices, dairy, beer, wine, detergents, pharmaceutical, and personal care products. In addition, the company offers v, sealants, or adhesives; and colorants for other applications, such as shopping bags, polybags, mulch films, OPP tapes, PU flexible foams, synthetic leather, fiber glass and buttons, paving blocks, artificial stones, cast PMMA, PP non-woven and spunbond, coatings, flexible PVCs, prosthetics, glass fiber reinforced nylon, and silicone rubber and elastomers. It sells its products through a network of suppliers, agents, and distributors. The company was founded in 1979 and is headquartered in Apeldoorn, the Netherlands. Holland Colours N.V. operates as a subsidiary of Holland Pigments BV.

Earnings Per Share

As for profitability, HOLLAND COLOURS has a trailing twelve months EPS of €6.02.

PE Ratio

HOLLAND COLOURS has a trailing twelve months price to earnings ratio of 15.61. Meaning, the purchaser of the share is investing €15.61 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.62%.

Sales Growth

HOLLAND COLOURS’s sales growth is 13.8% for the ongoing quarter and 13.8% for the next.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Jul 15, 2024, the estimated forward annual dividend rate is 3.01 and the estimated forward annual dividend yield is 3.24%.

Moving Average

HOLLAND COLOURS’s worth is under its 50-day moving average of €96.91 and above its 200-day moving average of €93.31.

Volume

Today’s last reported volume for HOLLAND COLOURS is 10 which is 95% below its average volume of 200.

More news about HOLLAND COLOURS.

5. SANOFI (SAN.PA)

7.4% sales growth and 5.82% return on equity

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

Earnings Per Share

As for profitability, SANOFI has a trailing twelve months EPS of €4.3.

PE Ratio

SANOFI has a trailing twelve months price to earnings ratio of 21.15. Meaning, the purchaser of the share is investing €21.15 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.82%.

More news about SANOFI.

Leave a Reply

Your email address will not be published. Required fields are marked *